Abivax (ABVX) Other Accumulated Expenses (2024 - 2026)
Abivax (ABVX) posted quarterly Other Accumulated Expenses of $71.5 million for Q1 2026, little changed quarter-over-quarter from $71.8 million in Q4 2025.
Abivax (ABVX) Other Accumulated Expenses (2024 - 2026) Analysis & Trends
Abivax's Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $71.5 million for Q1 2026.
- In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $71.5 million; the TTM figure through Mar 2026 stood at $71.5 million (changed N/A YoY), while the FY2025 annual figure was $71.8 million, up 36.89% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $71.5 million, roughly flat from $71.8 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $71.8 million in Q4 2025, with the low at $52.5 million in Q4 2024.
- The 3-year median for Other Accumulated Expenses is $71.5 million (2026), against an average of $65.3 million.
- Peak annual rise in Other Accumulated Expenses reached 36.89% in 2025, while the deepest fall reached 36.89% in 2025.
- Abivax's Other Accumulated Expenses stood at $52.5 million in 2024, then jumped by 36.89% to $71.8 million in 2025, then decreased by 0.4% to $71.5 million in 2026.
- Business Quant data shows ABVX's Other Accumulated Expenses at $71.5 million in Q1 2026, $71.8 million in Q4 2025, and $52.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.53 Mn |
| Dec 31, 2025 | 71.82 Mn |
| Dec 31, 2024 | 52.47 Mn |